Famvir for Treatment of Hearing in Unilateral Meniere's Disease

Summary

The specific aim of this study is to determine the efficacy of treatment with famciclovir in unilateral Meniere's Disease patients, specifically whether hearing can be improved. The investigators will determine the percentage of unilateral Meniere's Disease patients experiencing an absence of hearing fluctuation after 3 months of treatment with famciclovir as compared to the placebo arm.

Timeline

Start

2011-12

Primary completion

2015-01

Completion

2015-03

Outcome

Outcome not reported

Stopped: “HRI no longer conducting research.”

Drugs

Indications